Published in Histol Histopathol on March 01, 2013
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature (2014) 2.15
Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 0.81
High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2015) 0.79
Phosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2015) 0.79
Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 0.76
The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A (2002) 1.92
The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis (2002) 1.90
Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One (2010) 1.63
Pathological analysis of congenital cervical cysts in children: 20 years of experience at Chang Gung Memorial Hospital. Chang Gung Med J (2003) 1.61
Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol (2008) 1.58
Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet (2009) 1.53
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol (2002) 1.53
Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics (2010) 1.52
DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun (2010) 1.52
Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci (2003) 1.49
Phyllodes tumor in survivors of childhood osteosarcoma: a single institution's experience. J Pediatr Hematol Oncol (2014) 1.41
Hyperacute rejection from a donor who died of carbamate intoxication--a case report. Am J Emerg Med (2011) 1.39
High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet (2009) 1.39
Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res (2006) 1.38
Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol (2007) 1.37
Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics (2005) 1.32
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest (2013) 1.19
Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer (2011) 1.19
Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins. J Biol Chem (2002) 1.18
Papillary thyroid carcinomas with lung metastases. Thyroid (2004) 1.18
Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res (2011) 1.15
Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma. Histol Histopathol (2009) 1.15
Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med (2012) 1.14
Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res (2012) 1.14
Adrenal cystic lesions: a clinicopathological analysis of 25 cases with proposed histogenesis and review of the literature. Endocr Pathol (2008) 1.14
Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer. Mol Cell Proteomics (2012) 1.14
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol (2006) 1.12
Extrathyroid carcinoma showing thymus-like differentiation (CASTLE) tumor--a new case report and review of literature. Head Neck (2005) 1.11
Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol (2010) 1.11
Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology. J Proteome Res (2010) 1.10
Retroperitoneal teratomas in infancy and childhood. Pediatr Surg Int (2005) 1.09
Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics (2008) 1.09
Intra-abdominal cystic lymphangiomas in infancy and childhood. Chang Gung Med J (2004) 1.08
Ultrasonography-guided core-needle biopsy of parotid gland masses. AJNR Am J Neuroradiol (2004) 1.08
Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid (2005) 1.07
Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology. J Proteome Res (2011) 1.06
Value of CT in the discrimination of fatal from non-fatal stercoral colitis. Korean J Radiol (2012) 1.06
Necrotic stercoral colitis: importance of computed tomography findings. World J Gastroenterol (2011) 1.06
Congenital mixed malignant germ cell tumor involving cerebrum and orbit. J Perinat Med (2003) 1.06
High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol (2009) 1.05
Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys (2008) 1.05
Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer (2007) 1.04
Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck (2011) 1.04
Renal metastasis from papillary thyroid microcarcinoma. Acta Otolaryngol (2005) 1.04
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol (2011) 1.03
Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J Clin Oncol (2006) 1.02
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics. J Proteomics (2013) 1.02
A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma. Mod Pathol (2010) 1.01
Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Clin Cancer Res (2008) 1.01
Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry. FEBS J (2010) 1.00
Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers. J Proteomics (2012) 0.99
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis. Proteomics (2010) 0.99
Lipoblastoma/lipoblastomatosis: a clinicopathologic study of 16 cases in Taiwan. Pediatr Surg Int (2005) 0.98
Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories. Cancer (2007) 0.97
Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer (2008) 0.97
Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. J Proteome Res (2011) 0.97
Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer (2010) 0.97
MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res (2007) 0.96
Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma. Oral Oncol (2011) 0.96
Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab Invest (2011) 0.96
Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys (2008) 0.96
Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin Cancer Res (2008) 0.96
Ductal adenocarcinoma of the pancreas with huge cystic degeneration: a lesion to be distinguished from pseudocyst and mucinous cystadenocarcinoma. Int J Surg Pathol (2003) 0.96
Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study. Endocr J (2004) 0.95
Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J Proteome Res (2011) 0.95
Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection. PLoS One (2011) 0.95
An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Mol Cell Proteomics (2011) 0.94
Targeted methylation of CMV and E1A viral promoters. Biochem Biophys Res Commun (2010) 0.94
Incidental and nonincidental papillary thyroid microcarcinoma. Ann Surg Oncol (2008) 0.94
Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival. Head Neck (2010) 0.94
Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res (2009) 0.94
Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Clin Endocrinol (Oxf) (2007) 0.94
Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol (2006) 0.94
Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol Cell Proteomics (2009) 0.94
Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J Virol (2004) 0.93
New Labdane-type diterpenoids and anti-inflammatory constituents from Hedychium coronarium. Int J Mol Sci (2013) 0.93
Anaerobic thyroid abscess from a thyroid cyst after fine-needle aspiration. Head Neck (2002) 0.93
Feasibility of transumbilical lung wedge resection in a canine model. J Laparoendosc Adv Surg Tech A (2013) 0.93
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy. Biomaterials (2011) 0.92
PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1. EMBO J (2006) 0.92
Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer (2006) 0.92
Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas. Int J Clin Exp Pathol (2012) 0.92